| Disease | hartnup disease |
| Comorbidity | C0003864|inflammatory arthritis |
| Sentences | 1 |
| PubMedID- 20236522 | Barriers to care [1-5] continue to suppress the therapeutic advantages of early pharmacological intervention in inflammatory arthritis (ia) with disease-modifying anti-rheumatic drugs (dmards) [6-8]. |
Page: 1